{"version":"1.0","type":"rich","provider_name":"Buzzsprout","provider_url":"https://www.buzzsprout.com","author_url":"https://feeds.buzzsprout.com/1948695","width":500,"thumbnail_width":600,"thumbnail_height":600,"title":"Tackling Emerging Challenges in Tech-enabled Trials with Beth J Hoffman, PhD, CEO of Origami Therapeutics","author_name":"The Spark","html":"<iframe src=\"https://feeds.buzzsprout.com/1948695/episodes/11872034-tackling-emerging-challenges-in-tech-enabled-trials-with-beth-j-hoffman-phd-ceo-of-origami-therapeutics?client_source=oembed&amp;iframe=true\" width=\"100%\" height=\"200\" frameborder=\"0\" scrolling=\"no\" loading=\"lazy\" title=\"The Spark, Tackling Emerging Challenges in Tech-enabled Trials with Beth J Hoffman, PhD, CEO of Origami Therapeutics\"></iframe>","height":200,"thumbnail_url":"https://feeds.buzzsprout.com/rails/active_storage/representations/redirect/eyJfcmFpbHMiOnsiZGF0YSI6NTk4MTU5MTUsInB1ciI6ImJsb2JfaWQifX0=--c1ded346b57efcc74cee5e3fb650a4c30d8056a3/eyJfcmFpbHMiOnsiZGF0YSI6eyJmb3JtYXQiOiJqcGciLCJyZXNpemVfdG9fZmlsbCI6WzYwMCw2MDAseyJjcm9wIjoiY2VudHJlIn1dLCJzYXZlciI6eyJxdWFsaXR5Ijo2MH0sImNvbG91cnNwYWNlIjoic3JnYiJ9LCJwdXIiOiJ2YXJpYXRpb24ifX0=--0b154cb6b88107719b1a277923d35676ba5519cc/Audiogram%20Thumbnail_Alina%20Gologan.jpg"}